Kanamycin a
- Level
- Commodity
- Parent
- 51281600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51281653This classification denotes an aminoglycoside antibiotic with the molecular formula C18H36N4O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier EQK9Q303C5, chemically known as d-streptamine, o-3-amino-3-deoxy-.alpha.-d-glucopyranosyl-(1->6)-o-(6-amino-6-deoxy-.alpha.-d-glucopyranosyl-(1->4))-2-deoxy-, but more generally known as kanamycin a, which bears US NIH Compound Identifier 6032. European Medicines Agency schedules kanamycin a or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08362MIG. Most nations, for tariff purposes, schedule kanamycin a under HS 29419000. Kanamycin a bears US NLM identifiers UMLS ID C0022489 and NCI Concept Code C76151. SMILES: C1[C@H]([C@@H]([C@H]([C@@H]([C@H]1N)O[C@@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CN)O)O)O)O)O[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)N)O)N.
Same parent
Under 51281600 · 75Activities that produce or sell this
KBLI · 9Inherited from family 51280000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.